Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System (NCT05155956) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System
United States20 participantsStarted 2021-12-15
Plain-language summary
This is an observational cohort study addressing the incidence of cerebral microemboli and alterations of cerebral hemodynamic physiology of the Relay®Branch thoracic stent-graft system.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Enrollment in NCT03214601 based on presence of a thoracic aortic aneurysm, penetrating atherosclerotic ulcer, or chronic type B dissection that would require coverage of the brachiocephalic trunk and/or left carotid if a non-branching endograft were implanted Advanced heart failure with plan to treat with LVAD
* At least 18 years of age
* Patients enrolled prospectively must sign the informed consent form
* If patients underwent TCD monitoring during a previous RelayBranch procedure as part of routine clinical care, we will also incorporate their data in our analysis
Exclusion Criteria:
* Skull defect or skull surgery that will preclude monitoring
* Known lack of TCD temporal acoustic window (if had TCD in past)
* Expected surgical position will preclude access to the patient's head for monitoring